title: Continuous aerosolised tribavirin for respiratory syncytial virus infection in lung transplant recipients.
authors.forename: M
authors.initials: M
authors.lastname: Murris-Espin
authors.forename: A
authors.initials: A
authors.lastname: Didier
authors.forename: P
authors.initials: P
authors.lastname: Carre
authors.forename: J
authors.initials: J
authors.lastname: Icart
authors.forename: S
authors.initials: S
authors.lastname: Henry
authors.forename: P
authors.initials: P
authors.lastname: Leophonte
mesh_terms: D000336:Aerosols; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D016040:Lung Transplantation; D011183:Postoperative Complications / Q000188:drug therapy*; D012136:Respiratory Syncytial Viruses; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D010253:Respirovirus Infections / Q000188:drug therapy*; D012254:Ribavirin / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000336:Aerosols; D012254:Ribavirin